
Meningococcal Disease Vaccine Global Market Report 2025
Description
Meningococcal Disease Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on meningococcal disease vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for meningococcal disease vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The meningococcal disease vaccine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Vaccine Type: Conjugate Vaccines; Polysaccharide Vaccines; Recombinant Vaccines; Live Attenuated Vaccines
2) By Age Group: Infants; Children; Adults; Older Adults
3) By Indication: Preventive Vaccination; Post-Exposure Prophylaxis; Travel-Related Vaccination; Outbreak Response
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Conjugate Vaccines: Monovalent Conjugate Vaccines; Quadrivalent Conjugate Vaccines; Pediatric Conjugate Vaccines; Adolescent Or Adult Conjugate Vaccines
2) By Polysaccharide Vaccines: Bivalent Polysaccharide Vaccines; Trivalent Polysaccharide Vaccines; Quadrivalent Polysaccharide Vaccines; Age-Specific Polysaccharide Formulations
3) By Recombinant Vaccines: Serogroup B Recombinant Protein Vaccines; Multicomponent Recombinant Vaccines; Outer Membrane Vesicle (OMV) Based Recombinant Vaccines
4) By Live Attenuated Vaccines: Experimental Intranasal Live Attenuated Vaccines; Genetically Engineered Attenuated Strain Vaccines; Combined Live Attenuated Vaccines
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Sanofi SA; Novartis AG; GlaxoSmithKline plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on meningococcal disease vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for meningococcal disease vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The meningococcal disease vaccine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Vaccine Type: Conjugate Vaccines; Polysaccharide Vaccines; Recombinant Vaccines; Live Attenuated Vaccines
2) By Age Group: Infants; Children; Adults; Older Adults
3) By Indication: Preventive Vaccination; Post-Exposure Prophylaxis; Travel-Related Vaccination; Outbreak Response
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Conjugate Vaccines: Monovalent Conjugate Vaccines; Quadrivalent Conjugate Vaccines; Pediatric Conjugate Vaccines; Adolescent Or Adult Conjugate Vaccines
2) By Polysaccharide Vaccines: Bivalent Polysaccharide Vaccines; Trivalent Polysaccharide Vaccines; Quadrivalent Polysaccharide Vaccines; Age-Specific Polysaccharide Formulations
3) By Recombinant Vaccines: Serogroup B Recombinant Protein Vaccines; Multicomponent Recombinant Vaccines; Outer Membrane Vesicle (OMV) Based Recombinant Vaccines
4) By Live Attenuated Vaccines: Experimental Intranasal Live Attenuated Vaccines; Genetically Engineered Attenuated Strain Vaccines; Combined Live Attenuated Vaccines
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Sanofi SA; Novartis AG; GlaxoSmithKline plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Meningococcal Disease Vaccine Market Characteristics
- 3. Meningococcal Disease Vaccine Market Trends And Strategies
- 4. Meningococcal Disease Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 5. Global Meningococcal Disease Vaccine Growth Analysis And Strategic Analysis Framework
- 5.1. Global Meningococcal Disease Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Meningococcal Disease Vaccine Market Growth Rate Analysis
- 5.4. Global Meningococcal Disease Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Meningococcal Disease Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Meningococcal Disease Vaccine Total Addressable Market (TAM)
- 6. Meningococcal Disease Vaccine Market Segmentation
- 6.1. Global Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Conjugate Vaccines
- Polysaccharide Vaccines
- Recombinant Vaccines
- Live Attenuated Vaccines
- 6.2. Global Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Infants
- Children
- Adults
- Older Adults
- 6.3. Global Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Preventive Vaccination
- Post-Exposure Prophylaxis
- Travel-Related Vaccination
- Outbreak Response
- 6.4. Global Meningococcal Disease Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Other Distribution Channels
- 6.5. Global Meningococcal Disease Vaccine Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinics
- Homecare
- Other End-Users
- 6.6. Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Monovalent Conjugate Vaccines
- Quadrivalent Conjugate Vaccines
- Pediatric Conjugate Vaccines
- Adolescent Or Adult Conjugate Vaccines
- 6.7. Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Polysaccharide Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bivalent Polysaccharide Vaccines
- Trivalent Polysaccharide Vaccines
- Quadrivalent Polysaccharide Vaccines
- Age-Specific Polysaccharide Formulations
- 6.8. Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Serogroup B Recombinant Protein Vaccines
- Multicomponent Recombinant Vaccines
- Outer Membrane Vesicle (OMV) Based Recombinant Vaccines
- 6.9. Global Meningococcal Disease Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Experimental Intranasal Live Attenuated Vaccines
- Genetically Engineered Attenuated Strain Vaccines
- Combined Live Attenuated Vaccines
- 7. Meningococcal Disease Vaccine Market Regional And Country Analysis
- 7.1. Global Meningococcal Disease Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Meningococcal Disease Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Meningococcal Disease Vaccine Market
- 8.1. Asia-Pacific Meningococcal Disease Vaccine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Meningococcal Disease Vaccine Market
- 9.1. China Meningococcal Disease Vaccine Market Overview
- 9.2. China Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Meningococcal Disease Vaccine Market
- 10.1. India Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Meningococcal Disease Vaccine Market
- 11.1. Japan Meningococcal Disease Vaccine Market Overview
- 11.2. Japan Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Meningococcal Disease Vaccine Market
- 12.1. Australia Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Meningococcal Disease Vaccine Market
- 13.1. Indonesia Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Meningococcal Disease Vaccine Market
- 14.1. South Korea Meningococcal Disease Vaccine Market Overview
- 14.2. South Korea Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Meningococcal Disease Vaccine Market
- 15.1. Western Europe Meningococcal Disease Vaccine Market Overview
- 15.2. Western Europe Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Meningococcal Disease Vaccine Market
- 16.1. UK Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Meningococcal Disease Vaccine Market
- 17.1. Germany Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Meningococcal Disease Vaccine Market
- 18.1. France Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Meningococcal Disease Vaccine Market
- 19.1. Italy Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Meningococcal Disease Vaccine Market
- 20.1. Spain Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Meningococcal Disease Vaccine Market
- 21.1. Eastern Europe Meningococcal Disease Vaccine Market Overview
- 21.2. Eastern Europe Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Meningococcal Disease Vaccine Market
- 22.1. Russia Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Meningococcal Disease Vaccine Market
- 23.1. North America Meningococcal Disease Vaccine Market Overview
- 23.2. North America Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Meningococcal Disease Vaccine Market
- 24.1. USA Meningococcal Disease Vaccine Market Overview
- 24.2. USA Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Meningococcal Disease Vaccine Market
- 25.1. Canada Meningococcal Disease Vaccine Market Overview
- 25.2. Canada Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Meningococcal Disease Vaccine Market
- 26.1. South America Meningococcal Disease Vaccine Market Overview
- 26.2. South America Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Meningococcal Disease Vaccine Market
- 27.1. Brazil Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Meningococcal Disease Vaccine Market
- 28.1. Middle East Meningococcal Disease Vaccine Market Overview
- 28.2. Middle East Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Meningococcal Disease Vaccine Market
- 29.1. Africa Meningococcal Disease Vaccine Market Overview
- 29.2. Africa Meningococcal Disease Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Meningococcal Disease Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Meningococcal Disease Vaccine Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Meningococcal Disease Vaccine Market Competitive Landscape And Company Profiles
- 30.1. Meningococcal Disease Vaccine Market Competitive Landscape
- 30.2. Meningococcal Disease Vaccine Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 31. Meningococcal Disease Vaccine Market Other Major And Innovative Companies
- 31.1. Hualan Biological Engineering Inc.
- 31.2. Beijing Tiantan Biological Products Corporation Limited
- 31.3. Serum Institute of India Pvt. Ltd.
- 31.4. Walvax Biotechnology Co. Ltd.
- 31.5. Incepta Pharmaceuticals Ltd.
- 31.6. CanSino Biologics Inc.
- 31.7. EuBiologics Co. Ltd.
- 31.8. Biovac Institute
- 31.9. Shantha Biotech
- 31.10. Bio-Manguinhos
- 31.11. Biomed Pvt. Ltd.
- 31.12. Chengdu Kanghua Biological Products Co. Ltd.
- 31.13. Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd.
- 31.14. Finlay Institute of Vaccines
- 31.15. Immunopreparat
- 32. Global Meningococcal Disease Vaccine Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Meningococcal Disease Vaccine Market
- 34. Recent Developments In The Meningococcal Disease Vaccine Market
- 35. Meningococcal Disease Vaccine Market High Potential Countries, Segments and Strategies
- 35.1 Meningococcal Disease Vaccine Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Meningococcal Disease Vaccine Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Meningococcal Disease Vaccine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.